📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Indi

1.1 - Company Overview

Indi Logo

Indi

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of diagnostic products leveraging emerging technologies to help physicians and patients diagnose and manage complex diseases, such as cancer, diabetes, and Alzheimer’s, through non-invasive blood tests that monitor tens to hundreds of disease markers simultaneously.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Indi

Precipio Logo

Precipio

HQ: United States Website
  • Description: Provider of cancer diagnostics and personalized medicine, offering hematopathology clinical diagnostic services and SmartPath second-opinion services for treatment plan validation, molecular testing reagents including HemeScreen, Bloodhound BCR-ABL1, and HemeScreen AML, and IV-Cell culture media for multi-cell lineage with simplified workflow and clinical accuracy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Precipio company profile →
OncoEthix Logo

OncoEthix

HQ: Switzerland Website
  • Description: Provider of cancer drug development, advancing a portfolio of three to five promising oncology compounds through clinical development; a private Swiss company founded in 2007.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OncoEthix company profile →
Biofidelity Logo

Biofidelity

HQ: United Kingdom Website
  • Description: Provider of molecular diagnostic assays and platforms for rapid detection of target DNA sequences and actionable genomic biomarkers, with applications in oncology, prenatal testing, and infectious disease. Products include ASPYRE-Lung for guideline-recommended lung cancer biomarkers with results in days, and ASPYRE, a chemistry platform usable on existing PCR instruments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biofidelity company profile →
SciBase Logo

SciBase

HQ: Sweden Website
  • Description: Provider of medical devices leveraging Electrical Impedance Spectroscopy (EIS) to detect malignant melanoma and assess skin barrier function. Products include Nevisense, a point-of-care platform using EIS and AI for non-invasive melanoma detection and objective clinical decision-making, and Nevisense Go, a portable EIS device for detailed skin barrier assessment in research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SciBase company profile →
Kura Oncology Logo

Kura Oncology

HQ: United States Website
  • Description: Provider of precision medicines for solid tumors and blood cancers, advancing investigational therapies including ziftomenib for AML with specific mutations, tipifarnib for HRAS-mutant head and neck squamous cell carcinoma and other cancers, and KO-2806, a next-generation FTI for advanced solid tumors; also conducts clinical trials and offers expanded access programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kura Oncology company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Indi

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Indi

2.2 - Growth funds investing in similar companies to Indi

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Indi

4.2 - Public trading comparable groups for Indi

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Indi

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Indi

What does Indi do?

Indi is a provider of diagnostic products leveraging emerging technologies to help physicians and patients diagnose and manage complex diseases, such as cancer, diabetes, and Alzheimer’s, through non-invasive blood tests that monitor tens to hundreds of disease markers simultaneously.

Who are Indi's competitors?

Indi's competitors and similar companies include Precipio, OncoEthix, Biofidelity, SciBase, and Kura Oncology.

Where is Indi headquartered?

Indi is headquartered in United States.

How many employees does Indi have?

Indi has 1,000 employees 🔒.

When was Indi founded?

Indi was founded in 2010 🔒.

What sector and industry vertical is Indi in?

Indi is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Indi

Who are the top strategic acquirers in Indi's sector and industry

Top strategic M&A buyers and acquirers in Indi's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Indi?

Top strategic M&A buyers groups and sectors for Indi include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Indi's sector and industry vertical

Which are the top PE firms investing in Indi's sector and industry vertical?

Top PE firms investing in Indi's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Indi's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Indi's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Indi's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Indi include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Indi's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Indi?

The key public trading comparables and valuation benchmarks for Indi include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Indi for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Indi with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Indi's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Indi with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Indi's' sector and industry vertical?

Access recent funding rounds and capital raises in Indi's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Indi